Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

psychiatric diseases

- PMLiVE

Bayer’s Eylea data not suitable, says IQWiG

German HTA body unhappy with Lucentis comparison data and turns down Bayer-Regeneron wet AMD drug

- PMLiVE

ACC and Boehringer develop CME programme in China

Will focus on stroke prevention in atrial fibrillation

EISAI

Eisai “appalled” at decision not to recommend Fycompa in Germany

Regulator says pharma company filed inadequate comparison data for its epilepsy drug

- PMLiVE

Swedish regulator rules Boehringer press release is advertising

German pharma company fails to appeal decision

- PMLiVE

UCB signs research deal for novel neuroscience drugs

Partners with structural biology company ConfometRx

- PMLiVE

Merck to develop biosimilars with Samsung-Biogen joint venture

Agreement with Samsung Bioepis covers several candidates

Pharma deals during January 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Merck & Co extends autoimmune collaboration with Lycera

New deal could be worth more than $300m to the US biopharma company

EU funds ‘human brain’ computing project

Project could ultimately help develop personalised neurological treatments

EU flag

Five pharma companies begin antibiotic research programme

Sanofi, GSK and AstraZeneca among the collaborators on European projects

- PMLiVE

Endo to collaborate with India-based CRO GVK Biosciences

Will develop small molecule against undisclosed target in pain

- PMLiVE

Global academic research alliance to speed drug development

Includes centres from UK, US, Canada, Germany and Belgium

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links